Topic: IFFGD, General Interest
The process of drug development, review, delivery, and use is one that involves many stakeholders, including industries, regulators, physicians, and patients. All play roles that influence treatment outcomes. The illness experiences and perceptions of patients are key components to understanding a disease and providing safe and effective treatments. Looking at the experience of the IBS community with the drug alosetron as an example, this article reflects upon how treatment delivery can break down, and actions that can help ensure that safer, effective, treatments are made available to patients in need.Topics: IFFGD, General Interest
Brochure, Fact Sheet: The Neurobiology Basis of Mind Body MedicineNEU
How do the mind and body interact with each other and the environment . . . and in this process actively maintain health and prevent disease? This accessable publication describes the basis for a growing awareness of an evolving convergence of many "alternative" concepts of health and disease with cutting edge concepts proposed by science. This is information that can be helpful to anyone with a chronic digestive disorder. A summary of a 1998 conference involving internationally recognized scientific leaders, and a group of prominent and unique practitioners of mind-body medicine.
Also available offline as a 22 page soft-cover color booklet (8.5" x 11"). Contact IFFGD for details.Topics: Brain-Gut, CAM, Complementary & Alternative Treatments, IFFGD, General Interest, Irritable Bowel Syndrome (IBS), Stress
Brochure, Fact Sheet: Personal Daily Diary (Online version)PDD
Use this Personal Daily Diary for 2-4 weeks to help you get the most out of your next doctor visit.
The objective of using this Daily Diary is to gain a better understanding of your bowel disorder.
There is a growing understanding of the multi-faceted nature of functional gastrointestinal disorders. Symptoms, behaviors, and treatment outcomes for individuals with these disorders relate to disturbances in gastrointestinal motility and sensation that is effected by interactions that take place via the brain-gut axis. To understand and study these conditions, physicians and researchers must become familiar with evolving knowledge that integrates basic science, physiology, clinical medicine, psychology, and psychiatry. Indicated below are some of the highlights of the presentations at the 4th International Symposium for Functional Gastrointestinal Disorders, which we believe truly reflect the developing areas of research in irritable bowel syndrome (IBS) and the functional gastrointestinal (GI) disorders.
Our understanding of the functional GI disorders is changing, including the mechanisms that contribute to symptom generation, methods of assessing and diagnosing the disorders, and approaches to treatment. As indicated by data presented across multiple disciplines at this symposium - basic, mechanistic, physiological, clinical, and epidemiological - the clinical expression of the functional GI disorders includes a composite of several physiological components. In effect, there is no one factor that appears to be involved in the development of the disorders (etiology), nor is there one specific treatment.
Until the mid-twentieth century, healers relied upon their collective and individual experience to select the best remedy for a patient's complaint. Even today, most treatments are trial and error. Physicians, almost unique among healers, have sought scientific bases for their treatments, and their most powerful tool is the randomized clinical trial (RCT). Reviewed 2009.
A summary of presentations from over 80 experts that address the way research and science are improving our understanding of functional GI disorders, and the new avenues being investigated. Topics are covered such as, who is more likely to get a functional GI disorder, how do brain-gut interactions influence symptoms, diagnosis and treatment approaches, and what's new on the treatment horizon.
Fact Sheet: Dietary Fiber: What is it?200
Much is published on the benefits of "fiber" in the diet. Nevertheless, there is some confusion over what constitutes dietary fiber. Moreover, some of its proclaimed benefits are controversial. Therefore, it is a challenge to determine if, how much, and what kind of fiber one should take. This article addresses the nature of dietary fiber; its sources; its commonly accepted benefits, especially for the intestinal tract; and how to achieve sufficient daily fiber intake. Reviewed and updated 2009.
For many people, taking medication is a regular part of the daily routine, and these medicines are relied upon to treat disease and improve health. Although medicines can make you feel better and help you get well, it's important to know that all medicines, both prescription and over-the-counter, have risks as well as benefits.Topics: Constipation, difficult to pass stools, Diarrhea, loose stools, IFFGD, General Interest, Irritable Bowel Syndrome (IBS), Motility, Other Disorders/Symptoms, Pain Management
Fact Sheet: What is Evidence-based Medicine?204
From the 17th to the late 20th century, doctors often acted upon anecdote, opinion, and tradition. As a result many useless and even some harmful treatments were employed. Evidence-based medicine is a late 20th century innovation. It is the "conscientious, explicit and judicious use of the current best evidence from clinical care research in making decisions about the care of individual patients." It depends upon the accumulation of data from treating patients. This article describes the challenges and methods used in this process. Reviewed and updated 2009.
Documents listed on this page are available for download in Adobe’s PDF format. If you don’t have Adobe Reader, please visit Adobe’s site to download it. It’s free!